Extract

To evaluate the efficacy of YM155 based on the percentage of subjects that obtain a PSA response. PSA response is defined as a ≥ 50% reduction in PSA that is confirmed by a second PSA value 3 weeks apart. The reference PSA value for these decreases is the baseline PSA value.

Inclusion criteria

• Male adults with Hormone Refractory Prostate Cancer who have progressed, as evidenced by PSA progression or progression of measurable disease, after at least 1 prior chemotherapy regimen

Links

• euctr
• ictrp
• ictrp
• euctr